Cargando…
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting
INTRODUCTION: Increased post-marketing reports of interstitial lung disease in Japan have been recognized. An understanding of its regional groundings can be important for the global pharmacovigilance community. OBJECTIVE: The objective of this study was to explore the correlation between high rates...
Autores principales: | Iwasa, Eiko, Fujiyoshi, Yu, Kubota, Yuki, Kimura, Ryota, Chandler, Rebecca E., Taavola, Henric, Norén, G. Niklas, Wakao, Rika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575479/ https://www.ncbi.nlm.nih.gov/pubmed/32617874 http://dx.doi.org/10.1007/s40264-020-00968-7 |
Ejemplares similares
-
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
por: Wakao, Rika, et al.
Publicado: (2019) -
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020) -
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022) -
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan
por: Wakao, Rika, et al.
Publicado: (2021) -
Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan
por: Uzu, Shinobu, et al.
Publicado: (2022)